Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Hp 549
1. 55453-87-7
2. 2-(11-oxo-6,11-dihydrodibenzo[b,e]oxepin-2-yl)acetic Acid
3. 6,11-dihydro-11-oxo-dibenz[b,e]oxepin-2-acetic Acid
4. Artil
5. Hp 549
6. 2-(11-oxo-6h-benzo[c][1]benzoxepin-2-yl)acetic Acid
7. P 720549
8. 6,11-dihydro-11-oxodibenz[b,e]oxepin-2-acetic Acid
9. Dibenz[b,e]oxepin-2-acetic Acid, 6,11-dihydro-11-oxo-
10. (11-oxo-6,11-dihydrodibenzo[b,e]oxepin-2-yl)acetic Acid
11. Hp-549
12. Nsc-300907
13. 6,11-dihydro-11-oxodibenz(b,e)oxepin-2-acetic Acid
14. Olopatadine Related Compound C
15. 2kh283q0z5
16. Nsc300907
17. Dibenz(b,e)oxepin-2-acetic Acid, 6,11-dihydro-11-oxo-
18. P-720549
19. Isoxepacum
20. 2-(11-oxo-6,11-dihydrodibenzo-[b,e]oxepin-2-yl)acetic Acid
21. Isoxepacum [inn-latin]
22. (11-oxo-6,11-dihydrodibenzo[b,e]oxepin-2-yl)acetic Acid (isoxepac)
23. Nd4-b2
24. Nsc 300907
25. Brn 1320243
26. Isoxepac [usan:inn:ban]
27. Unii-2kh283q0z5
28. Artil (tn)
29. Isoxepac [usan]
30. Isoxepac (usan/inn)
31. Isoxepac [inn]
32. Isoxepac [mi]
33. 6,e]oxepin-2-acetic Acid
34. Dsstox_cid_31561
35. Dsstox_rid_97446
36. Dsstox_gsid_57772
37. Schembl24970
38. 5-18-08-00457 (beilstein Handbook Reference)
39. Chembl33211
40. 11-oxo-6,11-dihydrodibenz[b,e]oxepin-2-acetic Acid
41. Zinc1595
42. Dtxsid8057772
43. Chebi:135102
44. Bcp12544
45. Olopatadine Usp Related Compound C
46. Tox21_113815
47. Dibenz[b, 6,11-dihydro-11-oxo-
48. Mfcd00242952
49. S5044
50. Akos015895231
51. Ab05479
52. Ac-4725
53. Ccg-267128
54. Hy-w050088
55. Ncgc00253693-01
56. Ts-03511
57. Cas-55453-87-7
58. Db-002606
59. Hp-720549
60. Cs-0031651
61. D4242
62. Ft-0630680
63. P-549
64. D04638
65. Olopatadine Related Compound C [usp-rs]
66. 453d877
67. A830652
68. 6h-11-oxodibenzo[b,e]oxepin-2-acetic Acid
69. Q-100635
70. 6,11-hydro-11-oxo-dibenz[b,e]oxepin-2-acetic Acid
71. Olopatadine Related Compound C [usp Impurity]
72. Q27254870
73. 6,11-dihydro-11-oxodibenz[b,e]oxepin-2-yl Acetic Acid
74. 2-(11-oxo-6,11-dihydrodibenzo[b,e]oxepin-2-yl)aceticacid
75. (11-oxo-6,11-dihydro-dibenzo[b,e]oxepin-2-yl)-acetic Acid
76. 6,11-dihydro-11-oxodibenzo[b,e]oxepin-2-acetic Acid
77. 2-{2-oxo-9-oxatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,12,14-hexaen-5-yl}acetic Acid
| Molecular Weight | 268.26 g/mol |
|---|---|
| Molecular Formula | C16H12O4 |
| XLogP3 | 2.4 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 2 |
| Exact Mass | 268.07355886 g/mol |
| Monoisotopic Mass | 268.07355886 g/mol |
| Topological Polar Surface Area | 63.6 Ų |
| Heavy Atom Count | 20 |
| Formal Charge | 0 |
| Complexity | 392 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Market Place
ABOUT THIS PAGE
A CAS-55453-87-7 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of CAS-55453-87-7, including repackagers and relabelers. The FDA regulates CAS-55453-87-7 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. CAS-55453-87-7 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of CAS-55453-87-7 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A CAS-55453-87-7 supplier is an individual or a company that provides CAS-55453-87-7 active pharmaceutical ingredient (API) or CAS-55453-87-7 finished formulations upon request. The CAS-55453-87-7 suppliers may include CAS-55453-87-7 API manufacturers, exporters, distributors and traders.
click here to find a list of CAS-55453-87-7 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
CAS-55453-87-7 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of CAS-55453-87-7 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right CAS-55453-87-7 GMP manufacturer or CAS-55453-87-7 GMP API supplier for your needs.
A CAS-55453-87-7 CoA (Certificate of Analysis) is a formal document that attests to CAS-55453-87-7's compliance with CAS-55453-87-7 specifications and serves as a tool for batch-level quality control.
CAS-55453-87-7 CoA mostly includes findings from lab analyses of a specific batch. For each CAS-55453-87-7 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
CAS-55453-87-7 may be tested according to a variety of international standards, such as European Pharmacopoeia (CAS-55453-87-7 EP), CAS-55453-87-7 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (CAS-55453-87-7 USP).
LOOKING FOR A SUPPLIER?
